NCT04906382 2025-02-13
Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer
Ohio State University Comprehensive Cancer Center
Phase EARLY_PHASE1 Terminated
Clinical Trials
4 trialsNCT00736450 2023-10-24
Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
University of Nebraska
Phase EARLY_PHASE1 Terminated
NCT00651976 2018-10-15
Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Terminated
NCT00663910 2017-01-02
Topical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer
The Cleveland Clinic
Phase EARLY_PHASE1 Terminated